A concussion is often described as a "mild" traumatic brain injury. Yet repeated blows to the head rarely feel mild, and ...

A study in mice and human tissue suggests psilocybin protects against peripheral neuropathy, a common side effect of ...

The safety and efficacy of psilocybin assisted therapy to treat MDD is still under investigation and none of Optimi’s psilocybin drug products received market authorization by Health Canada.

State regulators have backed off pursuing sizable fee increases on Oregon’s magic mushroom businesses after dire warnings ...

Psilocybin and standard antidepressants both reduce the brain’s tendency to view the world through a negative lens. The ...

Unsupervised use of psilocybin, or “magic mushrooms,” has accelerated among all age groups in the United States, but especially among adolescents and people 30 and older, a new study found. “The ...

Colorado is on the brink of launching state-regulated psychedelic mushroom programs, with licenses for “healing centers” expected to be issued by late spring or early summer. The state is following in ...

Health Canada-authorized trial to evaluate a single supervised dose of natural psilocybin, with dosing expected to be completed by the end of ...

Psilocybin, a naturally occurring psychedelic compound found in “magic mushrooms,” has been touted as a potential game-changer for depression and other psychiatric disorders. Over the past two decades ...

Optimi Health Corp. , a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, announced plans to initiate a multisite Phase 2 clinical trial evaluat ...

Oregon was the first state to legalize psilocybin for therapeutic use in 2020. Now, some psilocybin workers warn that the state's program could "collapse." ...